| Surface-enhanced Raman spectroscopy of blood plasma and serum using Ag and Au nanoparticles: a systematic study A Bonifacio, S Dalla Marta, R Spizzo, S Cervo, A Steffan, A Colombatti, ... Analytical and Bioanalytical Chemistry 406, 2355-2365, 2014 | 201 | 2014 |
| Label-free surface-enhanced Raman spectroscopy of biofluids: fundamental aspects and diagnostic applications A Bonifacio, S Cervo, V Sergo Analytical and bioanalytical chemistry 407, 8265-8277, 2015 | 195 | 2015 |
| Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression SR Baglio, T Lagerweij, M Pérez-Lanzón, XD Ho, N Léveillé, SA Melo, ... Clinical Cancer Research 23 (14), 3721-3733, 2017 | 165 | 2017 |
| HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study C Romagnolo, AE Leon, ASC Fabricio, M Taborelli, J Polesel, L Del Pup, ... Gynecologic oncology 141 (2), 303-311, 2016 | 133 | 2016 |
| Surface-enhanced Raman spectroscopy of urine for prostate cancer detection: a preliminary study G Del Mistro, S Cervo, E Mansutti, R Spizzo, A Colombatti, P Belmonte, ... Analytical and Bioanalytical Chemistry 407, 3271-3275, 2015 | 119 | 2015 |
| SERS analysis of serum for detection of early and locally advanced breast cancer S Cervo, E Mansutti, G Del Mistro, R Spizzo, A Colombatti, A Steffan, ... Analytical and bioanalytical chemistry 407, 7503-7509, 2015 | 80 | 2015 |
| An effective multisource informed consent procedure for research and clinical practice: an observational study of patient understanding and awareness of their roles as research … S Cervo, J Rovina, R Talamini, T Perin, V Canzonieri, P De Paoli, ... BMC medical ethics 14, 1-10, 2013 | 56 | 2013 |
| Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia andHelicobacter pyloriInfection Among Populations at Risk for Gastric Cancer V De Re, E Orzes, V Canzonieri, S Maiero, M Fornasarig, L Alessandrini, ... Clinical and translational gastroenterology 7 (7), e183, 2016 | 50 | 2016 |
| Metabolomics biomarkers of frailty in elderly breast cancer patients G Corona, J Polesel, L Fratino, G Miolo, F Rizzolio, D Crivellari, ... Journal of cellular physiology 229 (7), 898-902, 2014 | 50 | 2014 |
| Patient-centered cancer care programs in Italy: Benchmarking global patient education initiatives I Truccolo, C Cipolat Mis, S Cervo, L Dal Maso, M Bongiovanni, A Bearz, ... Journal of Cancer Education 31, 405-412, 2016 | 25 | 2016 |
| Drafting biological material transfer agreement: a ready-to-sign model for biobanks and biorepositories S Cervo, P De Paoli, E Mestroni, T Perin, L Escoffier, V Canzonieri, ... The International Journal of Biological Markers 31 (2), 211-217, 2016 | 11 | 2016 |
| Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization S Cervo, P De Paoli, T Perin, V Canzonieri, A Steffan The International journal of biological markers 30 (2), 243-251, 2015 | 6 | 2015 |
| Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. a case report with peculiar diagnostic and therapeutic implications G Miolo, A Ash, A Buonadonna, G Lo Re, E Torrisi, S Cervo, ... Cancer Biology & Therapy 15 (11), 1439-1443, 2014 | 2 | 2014 |
| Confronto tra due metodi per la misura nel siero della proteina 4 dell’epididimo umano (HE4) nella diagnosi di carcinoma ovarico AE Leon, E Squarcina, T Maggino, C Romagnolo, L Del Pup, S Carvo Biochim Clin 37, 200-7, 2013 | 2 | 2013 |
| Conservative treatment of coexisting microinvasive squamous and adenocarcinoma of the cervix: report of two cases and literature review F Sopracordevole, J Di Giuseppe, S Cervo, M Buttignol, G Giorda, ... OncoTargets and therapy, 539-544, 2016 | 1 | 2016 |
| HE4, CA125 and risk of ovarian malignancy algorithm (Roma) as diagnostic tools of ovarian cancer in patients with pelvic mass: an Italian multicenter prospective study C Romagnolo, AE Leon, ASC Fabricio, L Del Pup, C Papadakis, ... INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 25 (9), 528-529, 2015 | 1 | 2015 |
| Serum Cancer Biomarkers in Gastric A Steffan, S Cervo, V Fanotto, F Puglisi Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy, 107, 2019 | | 2019 |
| Serum Biomarkers in Gastric Cancer A Steffan, S Cervo, V Fanotto, F Puglisi Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy, 107-117, 2019 | | 2019 |
| COMPARISON BETWEEN OVARIAN MALIGNANCY ALGORITHM (ROMA) AND IOTA RISK MODEL (LR2) FOR DIFFERENTIAL DIAGNOSIS OF ADNEXAL MASSES: REAL-WORLD STUDY C Romagnolo, ASC Fabricio, AE Leon, M Taborelli, V Agnolon, ... INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 27, 421-421, 2017 | | 2017 |
| Tissue preservation, aliquoting methods and quality controls in biobanking V Canzonieri, S Cervo, T Perin, E Savaris, A Polizzi-Anselmo, P De Paoli, ... VIRCHOWS ARCHIV 471, S250-S250, 2017 | | 2017 |
Agostino Steffan MDI.R.C.C.S. Centro di Riferimento Oncologico Aviano (PN) Immunopatologia e Biomarcatori OncologiciVerified email at cro.it
